How Accredited Laboratories Support Device Submissions

A test report can confirm a result, but its value in a medical device submission depends on more than the measured number. Regulators, notified bodies, customers, and internal quality teams need confidence that the method was appropriate, the equipment was controlled, the personnel were qualified, and the data can be traced to the device under evaluation. Accredited laboratories provide the framework for that confidence.

For medical device manufacturers, laboratory selection is therefore not simply a purchasing decision. It is a regulatory and technical decision that affects verification planning, submission quality, remediation risk, and commercialization timing. Accreditation does not guarantee that every test will meet a program’s needs. It does, however, provide an independently assessed basis for evaluating whether a laboratory can competently perform specific work within its approved scope.

What Accreditation Demonstrates

ISO/IEC 17025 is the principal international standard for testing and calibration laboratory competence. An ISO/IEC 17025-accredited laboratory has been assessed by an accreditation body against requirements for impartiality, quality management, technical competence, equipment control, method validation, traceability, personnel qualifications, and reporting.

The practical implication is significant. A laboratory operating under an accredited quality system must show that its processes are not merely documented but implemented. Test instruments require suitable calibration and maintenance. Environmental conditions must be monitored when they can affect results. Deviations, nonconforming work, and complaints require controlled investigation. Records must support reconstruction of the work performed.

For a device manufacturer, these controls strengthen the credibility of the resulting evidence. They also reduce the risk of discovering late in a submission cycle that essential details were omitted, a method was applied outside its intended range, or traceability records cannot support a challenged result.

Accreditation is not a blanket statement that a laboratory is qualified for all medical device testing. The scope matters. A laboratory may be accredited for particular methods, standards, measurement ranges, products, or technical disciplines. A manufacturer evaluating electrical safety, acoustic output, ultrasound image quality, endoscope performance, or human factors validation should confirm that the relevant work is covered by the laboratory’s current scope and technical capability.

Why Accredited Laboratories Matter for Medical Devices

Medical device test programs often produce evidence for multiple decisions at once. The same data may support design verification, risk management, labeling claims, clinical evaluation, a 510(k) submission, technical documentation, or release of a design change. When the data must travel across engineering, quality, regulatory, and external review functions, documentation discipline becomes as important as the test execution itself.

Accredited laboratories help establish that discipline through defined procedures and controlled reporting. A complete report should identify the device configuration, sample identification, applicable method, acceptance criteria where applicable, equipment or measurement systems used, test conditions, results, deviations, and the authorized personnel responsible for review. The report must make clear what was tested and, equally important, what was not.

This clarity is especially valuable when a standard contains options, exclusions, or manufacturer-defined parameters. Consider an IEC electrical safety evaluation. The correct test setup may depend on the device’s intended environment, applied parts, power architecture, accessories, modes of operation, and essential performance functions. A report that simply states “pass” without documenting the applicable configuration and test conditions may not adequately support regulatory review.

The same principle applies to performance testing. For diagnostic ultrasound systems, transducer type, operating mode, output settings, imaging presets, and phantom selection can materially affect acoustic and image-quality results. For endoscopes, the relevant evaluation may include image quality, illumination, articulation, leak resistance, or compatibility characteristics. The laboratory must understand which measurements establish compliance for the specific device and intended use.

Accreditation and FDA ASCA Are Related but Different

For certain device standards, FDA’s Accreditation Scheme for Conformity Assessment, or ASCA, adds a separate layer of relevance. The ASCA program recognizes accreditation bodies and testing laboratories for specific FDA-recognized consensus standards and test methods. When applicable, testing performed by an ASCA-accredited laboratory may provide FDA with greater confidence in the conformity assessment process.

ISO/IEC 17025 accreditation and FDA ASCA accreditation should not be treated as interchangeable credentials. ISO/IEC 17025 addresses laboratory competence within an accredited scope. ASCA is tied to FDA-recognized standards and the program’s applicable requirements. Whether ASCA is relevant depends on the device type, regulatory pathway, standard, and submission strategy.

Manufacturers should determine early whether a planned test is intended to support an FDA submission under an ASCA-eligible standard, another market’s conformity assessment, internal verification, or several objectives. That decision influences laboratory selection, protocol content, report format, and the evidence needed to establish applicability.

How to Evaluate a Laboratory Before Testing Begins

The best time to assess a laboratory is before samples are shipped and before the verification protocol is finalized. A technically capable laboratory can still be the wrong fit if its accredited scope does not cover the intended method, its lead time conflicts with the design schedule, or its reporting format does not support the submission objective.

Start with the standard and the device configuration. Identify the exact edition, amendments, collateral and particular standards, applicable clauses, and known deviations. If the test plan relies on a customized method, determine whether the laboratory can validate or verify the method appropriately and explain how uncertainty, repeatability, or method limitations will be handled.

Next, review the laboratory’s scope rather than relying only on a general accreditation statement. The scope should indicate the relevant technical area and, where applicable, methods, measurements, and ranges. A broad claim of medical device testing is less useful than evidence of competence in the work required, such as dielectric strength, leakage current, acoustic power, ultrasound output measurements, materials characterization, or usability-related validation activities.

It is also appropriate to ask operational questions early. Confirm sample quantities, conditioning needs, fixtures, software versions, accessories, test modes, expected test duration, and reporting deliverables. If failures occur, establish how the laboratory will document the condition, preserve evidence, communicate preliminary observations, and support retesting after corrective action.

Speed matters, but it should be assessed carefully. A rapid quote and clear schedule are valuable when development milestones are fixed. The trade-off is that an accelerated timeline cannot compensate for an incomplete test plan or an undefined device configuration. Early technical review typically saves more time than attempting to resolve standard interpretation questions after testing has begun.

Build the Test Program Around Intended Use and Risk

A strong laboratory engagement begins with a complete device description. The laboratory should understand the intended use, user population, use environment, power source, patient contact classification, accessories, software-controlled functions, and safety-critical performance characteristics. These details affect the standards that apply and the way tests should be configured.

Risk management should inform the testing strategy, not sit beside it as a separate file. If a hazard analysis identifies risks related to excessive acoustic output, electrical shock, thermal exposure, misleading display information, loss of essential performance, or foreseeable use error, the verification plan should show how those risks are addressed. The laboratory’s role is to execute and document defined evaluations, while the manufacturer remains responsible for demonstrating that the overall evidence adequately addresses the device’s risks.

This distinction matters when interpreting a passing result. A device can pass an individual clause while the manufacturer still needs to evaluate system-level interactions, labeling adequacy, clinical relevance, or residual risk. Conversely, a test observation may expose an issue that is not a simple laboratory failure but a design-input or intended-use question requiring cross-functional assessment.

Treat the Report as a Controlled Regulatory Record

Test reports are often requested months or years after initial completion, during a submission review, audit, design change assessment, complaint investigation, or supplier evaluation. They should be managed as controlled quality records, with clear links to the tested sample, protocol, applicable standard, and device configuration.

Before authorizing final testing, manufacturers should verify that the sample represents the configuration they intend to market or clearly document any differences. Firmware revision, cable selection, enclosure changes, transducer updates, accessories, and manufacturing-process changes can affect applicability or invalidate assumptions made during testing. A high-quality report cannot correct a poorly controlled sample configuration.

When specialized medical device testing is required, Sigma Scientific Services combines ISO/IEC 17025 accreditation with FDA ASCA program accreditation for applicable work, supporting standards-based evidence across safety and performance disciplines. The most effective engagement begins with a defined device configuration, a clear regulatory objective, and a test plan that reflects the product’s real risks and intended use.

The useful question is not simply whether a laboratory is accredited. It is whether its accredited competence, applicable scope, technical methods, and reporting practices align with the exact evidence your device needs. That alignment is what turns laboratory testing into defensible regulatory support.